Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Topstories https://ift.tt/3jjsiDu